INGR vs SXT: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: INGR is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. INGR and SXT share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined INGR and SXT exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Ingredion Incorporated grinds corn and other crops into starches, sweeteners and texturizing ingredients that end up inside packaged food, beverages, paper and pharmaceuticals. The business reports in three segments: Texture & Healthful Solutions, the global specialty texturant arm that produced ~$627 million of second quarter net sales; Food and Industrial Ingredients in Latin America, at ~$611 million; and Food and Industrial Ingredients in the US and Canada, at ~$488 million. A fourth bucket called All Other holds the PureCircle stevia, sugar reduction and pea protein fortification businesses. Trailing twelve month revenue runs about ~$7.2 billion on a market capitalisation near ~$6.6 billion, and the company has been reshaping the portfolio hard, closing its Cabo plant in Brazil and selling ~51% of its Pakistan subsidiary for ~$165 million in June 2026.

Full INGR guide

Sensient Technologies is a Milwaukee-based manufacturer of colors, flavors, and functional ingredients used in food and beverage, pharmaceutical, nutraceutical, and personal-care products. It runs three reporting segments: Color (natural and synthetic color systems), Flavors & Extracts (flavor systems, extracts, essential oils, and dehydrated agricultural ingredients like garlic and onion), and Asia Pacific (color and flavor distribution plus products like chili powder and paprika across the Pacific Rim and India). The company sells specialized, formulation-critical ingredients that are a small share of a customer's cost but hard to swap out, which supports pricing power and sticky relationships.

Full SXT guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• INGR drivers: Corn costs pass through, so revenue and profit move separately; Texture & Healthful Solutions carries the mix shift.
• SXT drivers: Natural-color regulatory conversion; Capacity investment (Project Prism).

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The thermal event at the Argo plant held back volumes and added manufacturing cost through the first half, cutting gross margin to ~23% from ~26% a year earlier and taking US and Canada segment operating income down ~48% year to date. For SXT, the stock trades at a premium multiple (a trailing P/E in the mid-30s, above its long-run median), so much of the natural-color optimism may already be reflected in the price and disappointment could compress the valuation.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick INGR if you believe its drivers more; SXT if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the INGR and SXT guides.

INGR. Near ~$105 a share the stock carries about ~11 times trailing earnings and roughly ~9.5 times the midpoint of 2026 adjusted guidance, a visible discount to the branded specialty ingredient houses. That gap prices the commodity half of the business, the Argo disruption and the leverage still to arrive. Reported and adjusted earnings diverge unusually far this year because of the Cabo closure charges, the ~$44 million Pakistan disposal gain and the acquisition hedges, so the ~$9.15 to ~$9.75 reported guide sits well below the ~$10.30 to ~$10.90 adjusted one.

SXT. Q1 2026 was strong, with revenue up about 11% to ~$436 million, gross margin expanding to ~35%, and diluted EPS rising to ~$1.04, prompting management to raise full-year guidance. The trailing P/E in the mid-30s sits above Sensient's roughly 29x ten-year median, reflecting optimism about the natural-color opportunity. The ~1.4% dividend yield reflects a long, steadily growing payout history rather than a high-yield profile.

Headline figures (approximate, August 2026): INGR shows market cap ~$6.6B, revenue (ttm) ~$7.2B, net income (ttm) ~$592M, fy 2026 adjusted eps guidance ~$10.30 to ~$10.90; SXT shows revenue (ttm) ~$1.7B, q1 2026 revenue ~$436M (up ~11%), net income (ttm) ~$150M, 2026 eps guidance (gaap) ~$3.70 to $3.90.

INGR and SXT are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined INGR and SXT exposure against your real portfolio. It is not an investment adviser.